These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 19897532)

  • 1. Risk analysis and risk adapted on-site monitoring in noncommercial clinical trials.
    Brosteanu O; Houben P; Ihrig K; Ohmann C; Paulus U; Pfistner B; Schwarz G; Strenge-Hesse A; Zettelmeyer U
    Clin Trials; 2009 Dec; 6(6):585-96. PubMed ID: 19897532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The other side of clinical trial monitoring; assuring data quality and procedural adherence.
    Williams GW
    Clin Trials; 2006; 3(6):530-7. PubMed ID: 17170037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk-adapted monitoring is not inferior to extensive on-site monitoring: Results of the ADAMON cluster-randomised study.
    Brosteanu O; Schwarz G; Houben P; Paulus U; Strenge-Hesse A; Zettelmeyer U; Schneider A; Hasenclever D
    Clin Trials; 2017 Dec; 14(6):584-596. PubMed ID: 28786330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A decision rule for sequential monitoring of clinical trials with a primary and supportive outcome.
    Zhao Y; Grambsch PM; Neaton JD
    Clin Trials; 2007; 4(2):140-53. PubMed ID: 17456513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Centralized medical monitoring in phase III clinical trials: the National Surgical Adjuvant Breast and Bowel Project (NSABP) experience.
    Soran A; Nesbitt L; Mamounas EP; Lembersky B; Bryant J; Anderson S; Brown A; Passarello M
    Clin Trials; 2006; 3(5):478-85. PubMed ID: 17060221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management and interpretation of data obtained from clinical trials in pain management.
    Theodore BR; Gatchel RJ
    Pain Pract; 2008; 8(6):461-72. PubMed ID: 19000174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inadequate planning and reporting of adjudication committees in clinical trials: recommendation proposal.
    Dechartres A; Boutron I; Roy C; Ravaud P
    J Clin Epidemiol; 2009 Jul; 62(7):695-702. PubMed ID: 19135860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Individual patient meta-analysis of self-monitoring of an oral anticoagulation protocol.
    Perera R; Heneghan C; Fitzmaurice D;
    J Heart Valve Dis; 2008 Mar; 17(2):233-8. PubMed ID: 18512497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
    During MJ; Kaplitt MG; Stern MB; Eidelberg D
    Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring and reporting of the Women's Health Initiative randomized hormone therapy trials.
    Anderson GL; Kooperberg C; Geller N; Rossouw JE; Pettinger M; Prentice RL
    Clin Trials; 2007; 4(3):207-17. PubMed ID: 17715246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [How to prevent hazards and to reduce risk in clinical trials?].
    Czarkowski M
    Pol Merkur Lekarski; 2008 Dec; 25(150):534-8. PubMed ID: 19205390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A web-based clinical trial management system for a sham-controlled multicenter clinical trial in depression.
    Durkalski V; Wenle Zhao ; Dillon C; Kim J
    Clin Trials; 2010 Apr; 7(2):174-82. PubMed ID: 20083496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The NCI All Ireland Cancer Conference.
    Johnston PG; Daly PA; Liu E
    Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Designing a data and safety monitoring plan.
    Slimmer L; Andersen B
    West J Nurs Res; 2004 Nov; 26(7):797-803. PubMed ID: 15466615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Futility interim monitoring with control of type I and II error probabilities using the interim Z-value or confidence limit.
    Lachin JM
    Clin Trials; 2009 Dec; 6(6):565-73. PubMed ID: 19933716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Monitoring the safety of participants in randomised clinical trials: basis and methods].
    Tijssen JG
    Ned Tijdschr Geneeskd; 2008 Mar; 152(12):674-8. PubMed ID: 18438062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Quality control in clinical trials].
    Fukushima M
    Gan To Kagaku Ryoho; 1996 Jan; 23(2):172-82. PubMed ID: 8611045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Public clinical trials: which kind of monitoring should be used?].
    Cornu C; Binquet C; Thalamas C; Vigouroux C; Gaillard S; Ginhoux T; Vaz B; Jossan C; Félin A; Sailly A; Gueyffier F; Journot V; Kassaï B
    Therapie; 2013; 68(3):135-41. PubMed ID: 23886457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.